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background:  The molecular details of nuclear factor-kappaB (NF-kB) signaling during myocardial ischemia/reperfusion (I/R) injury remain 
poorly understood. We hypothesized that inhibition of NF-kB would prevent cell death.
methods:  We used transgenic mice overexpressing a mutant IkBα with consequent cardiac-specific silencing of NF-kB. Age-matched 
male wild-type (WT, C57BL/6), non-transgenic littermates (NTg) and IkBα transgenic (Tg) mice underwent a 30-min coronary occlusion 
followed by specified durations of reperfusion (1, 3, or 24 h). Assessment of infarct size, apoptosis, and molecular signaling was performed.
Results:  The infarct size was similar in WT and NTg mice, and significantly smaller in Tg mice. In addition, compared with WT and NTg 
mice, the percentage of apoptotic cardiomyocyte nuclei in Tg myocardium was significantly smaller compared with NTg and WT hearts 
(Figure). This decrease in apoptosis was corroborated by reduced levels of proapoptotic molecules, including cleaved Caspase-8 and 
phosphorylated MAP kinase p38 (p-p38), and increased levels of cytoprotective molecules, including phosphorylated GSK-3β and Akt in Tg 
mouse hearts.
conclusion:  We conclude that myocardial NF-kB signaling plays a detrimental role during acute I/R injury, and NF-kB inhibition protects 
against myocyte apoptosis via induction of a cytoprotective program. These molecular insights may be utilized to develop novel therapeutic 
strategies during myocardial ischemia and infarction in humans.
 
